# PS7:139 Efficacy and safety of rituximab in resistant sle

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ps7-139-efficacy-and-safety-of-rituximab-in-resistant-sle/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rahaf Zyad Attar,Osama Safdar,Mahvish Muzaffar,Suzan Attar,M Alhomeid |
| Citations | 0 |
| DOI | 10.1136/lupus-2018-abstract.182 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://lupus.bmj.com/content/lupusscimed/5/Suppl_1/A104.1.full.pdf |
| OpenAlex ID | https://openalex.org/W2795165410 |
| Type | conference-paper |
| Year | 2018 |

## Paper authors

- [Rahaf Zyad Attar](https://scholariq.org/researchers/rahaf-zyad-attar/)

## Paper primary topic

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.